XML 23 R12.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation
 6 Months Ended
Aug. 01, 2020
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
The compensation costs that have been charged against income were as follows (in thousands):

13-Weeks Ended26-Weeks Ended
August 1,
2020		August 3,
2019		August 1,
2020		August 3,
2019
Stock-based compensation expense by type:
Stock options
$— $— $90 $92 
Restricted stock units587 354 1,647 716 
Employee stock purchases
27 21 70 51 
Director deferred compensation23 24 47 47 
  Total stock-based compensation expense637 399 1,854 906 
Income tax benefit recognized168 89 423 203 
  Stock-based compensation expense, net of income tax$469 $310 $1,431 $703 

Expense for restricted stock units is shown net of forfeitures of $0.7 million and $0.5 million for the 13-weeks ended August 1, 2020 and August 3, 2019, respectively. Expense for restricted stock units is shown net of forfeitures of $0.9 million and $1.8 million for the 26-weeks ended August 1, 2020 and August 3, 2019, respectively.
We have granted the following equity awards:

13-Weeks Ended26-Weeks Ended
August 1,
2020		August 3,
2019		August 1,
2020		August 3,
2019
Stock options
— — 27,000 16,798 
Restricted stock unit awards
3,264 31,573 337,749 222,594 
Performance-based restricted stock unit awards
— — — 34,300 
Deferred stock units
1,120 1,288 3,263 2,315 
At August 1, 2020, the total compensation costs related to unvested restricted stock unit awards not yet recognized was $6.2 million and the weighted-average period over which such awards are expected to be recognized was 2.7 years. There were no compensation costs related to unvested stock options at August 1, 2020.

During the 13-weeks ended August 1, 2020 and August 3, 2019, no stock options were granted. The weighted-average grant date fair value of stock options granted during the 26-weeks ended August 1, 2020 and August 3, 2019 was $3.33 and $5.46 per share, respectively.
Under the 2012 Non-Employee Director Equity Plan (2012 Plan), no shares of our common stock were awarded during the 13-weeks ended August 1, 2020 or August 3, 2019. A total of 13,858 shares of our common stock were awarded during the 26-weeks ended August 3, 2019, as part of the annual equity award to directors in the first quarter.
The number of shares purchased, the average price per share and the weighted-average grant date fair value of shares purchased through our employee stock purchase plan were as follows:
13-Weeks Ended26-Weeks Ended
August 1,
2020		August 3,
2019		August 1,
2020		August 3,
2019
Shares purchased11,143 5,628 28,901 15,553 
Average price per share$8.60 $15.47 $9.03 $13.35 
Weighted-average fair value at grant date$2.39 $5.20 $3.51 $3.89